Home › NDC Lookup › RxCUI directory › RxCUI 1872384

15 ML sodium phosphate, dibasic 142 MG/ML / sodium phosphate, monobasic 276 MG/ML Injectio... — RxCUI 1872384

RxNorm drug concept · Semantic clinical drug
RxCUI 1872384 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1872384
Official name15 ML sodium phosphate, dibasic 142 MG/ML / sodium phosphate, monobasic 276 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asphosphorus 45 MMOL / sodium 60 MEQ per 15 ML Injection; sodium phosphates (phosphorus 45 MMOL / sodium 60 MEQ) in 15 ML Injection; sodium phosphate, dibasic 2.13 GM / sodium phosphate, monobasic 4.14 GM per 15 ML Injection; sodium phosphates (phosphorus 45 MMOL / sodium 60 MEQ) per 15 ML Injection
FDA products mapped14
Package NDCs mapped15
Reported Medicaid activity (SDUD)18,222 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 15 ML sodium phosphate, dibasic 142 MG/ML / sodi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 15 ML sodium phosphate, dibasic 142 MG/ML / sodium phosphate, monobasic 276 MG/ML Injection RxCUI 1872384

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Sodium phosphate, dibasic 236719
    • Sodium phosphate, monobasic 235496
    • Sodium phosphate, dibasic / sodium phosphate, monobasic 817886
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sodium phosphate, dibasic / sodium phosphate, monobasic Injection 1872383
    • Sodium phosphate, dibasic / sodium phosphate, monobasic Injectable Product 1159924
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sodium phosphate, dibasic 142 MG/ML 335591
    • Sodium phosphate, monobasic 276 MG/ML 336812

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sodium phosphate, dibasic 142 MG/ML SCDC · 335591
  • Sodium phosphate, monobasic 276 MG/ML SCDC · 336812
  • Sodium phosphate, dibasic / sodium phosphate, monobasic Injection SCDF · 1872383
  • Sodium phosphate, dibasic / sodium phosphate, monobasic Injectable Product SCDG · 1159924

📦 FDA Products & Package NDCs

14 products · 15 package NDCs
15 package NDCs map to RxCUI 1872384 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00409-7391-72 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7391-72) / 15 mL in 1... Sodium Phosphates Hospira, Inc. 2005-06-02
00517-7305-25 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-7305-25) / 5 mL in 1 V... Sodium Phosphates American Regent, Inc. 2024-06-21
00517-7315-25 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-7315-25) / 15 mL in 1... Sodium Phosphates American Regent, Inc. 2024-06-21
00517-7350-25 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-7350-25) / 50 mL in 1... Sodium Phosphates American Regent, Inc. 2024-06-21
63323-0170-05 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-170-05) / 5 mL in 1 V... Sodium Phosphates Fresenius Kabi USA, LLC 2000-09-06
63323-0170-15 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-170-15) / 15 mL in 1... Sodium Phosphates Fresenius Kabi USA, LLC 2000-09-06
63323-0881-16 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-881-16) / 15 mL in 1... Sodium Phosphates Fresenius Kabi USA, LLC 2022-03-30
63323-0884-06 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-884-06) / 5 mL in 1 V... Sodium Phosphates Fresenius Kabi USA, LLC 2022-03-30
63323-0886-56 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-886-56) / 50 mL in 1... Sodium Phosphates Fresenius Kabi USA, LLC 2022-03-30
65145-0200-25 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-200-25) / 5 mL in 1... SODIUM PHOSPHATES Caplin Steriles Limited 2026-03-10
65145-0201-25 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-201-25) / 15 mL in... SODIUM PHOSPHATES Caplin Steriles Limited 2026-03-10
65145-0202-25 25 VIAL, SINGLE-DOSE in 1 CARTON (65145-202-25) / 50 mL in... SODIUM PHOSPHATES Caplin Steriles Limited 2026-03-10
68462-0728-25 25 VIAL, SINGLE-DOSE in 1 CARTON (68462-728-25) / 5 mL in 1... SODIUM PHOSPHATES GLENMARK PHARMACEUTICALS INC., USA 2026-02-23
68462-0729-25 25 VIAL, SINGLE-DOSE in 1 CARTON (68462-729-25) / 15 mL in... SODIUM PHOSPHATES GLENMARK PHARMACEUTICALS INC., USA 2026-02-23
68462-0730-25 25 VIAL, SINGLE-DOSE in 1 CARTON (68462-730-25) / 50 mL in... SODIUM PHOSPHATES GLENMARK PHARMACEUTICALS INC., USA 2026-02-23
Observed labelers: Fresenius Kabi USA, LLC (5) · American Regent, Inc. (3) · Caplin Steriles Limited (3) · GLENMARK PHARMACEUTICALS INC., USA (3) · Hospira, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.